BCR-ABL-1 synthesis inhibitors are used to treat chronic myeloid leukemia (CML). These medications work by blocking the production of BCR-ABL and MCL-1 proteins, which cause cancer cells to grow and survive. One example is an injection called Synribo (omacetaxine), but it's been discontinued by its manufacturer.
Prices for popular BCR-ABL-1 Synthesis Inhibitor medications
OMACETAXINE treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up
